Orphan status for tuberculosis vaccine

被引:0
|
作者
Brierley, R
机构
来源
LANCET INFECTIOUS DISEASES | 2005年 / 5卷 / 11期
关键词
D O I
10.1016/S1473-3099(05)70256-5
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
引用
收藏
页码:677 / 677
页数:1
相关论文
共 50 条
  • [1] The status of tuberculosis vaccine development
    Schrager, Lewis K.
    Vekemens, Johan
    Drager, Nick
    Lewinsohn, David M.
    Olesen, Ole F.
    LANCET INFECTIOUS DISEASES, 2020, 20 (03): : E28 - E37
  • [2] New TB vaccine granted orphan drug status
    Lang, T
    Hill, AVS
    McShane, H
    Shah, R
    Towse, A
    Pritchard, C
    Garau, M
    BRITISH MEDICAL JOURNAL, 2005, 331 (7530): : 1476 - 1476
  • [3] Orphan drug status for personalized cancer vaccine BiovaxID
    Riedmann, Eva M.
    HUMAN VACCINES, 2011, 7 (05): : 493 - 494
  • [4] Current status of new tuberculosis vaccine in children
    Pang, Yu
    Zhao, Aihua
    Cohen, Chad
    Kang, Wanli
    Lu, Jie
    Wang, Guozhi
    Zhao, Yanlin
    Zheng, Suhua
    HUMAN VACCINES & IMMUNOTHERAPEUTICS, 2016, 12 (04) : 960 - 970
  • [5] Status of vaccine research and development of vaccines for tuberculosis
    Evans, Thomas G.
    Schrager, Lew
    Thole, Jelle
    VACCINE, 2016, 34 (26) : 2911 - 2914
  • [7] Orphan status for enzastaurin
    不详
    EUROPEAN JOURNAL OF CANCER, 2007, 43 (08) : 1225 - 1225
  • [8] Orphan status for fenretinide
    不详
    EUROPEAN JOURNAL OF CANCER, 2007, 43 (07) : 1112 - 1112
  • [9] Childhood tuberculosis: no longer an orphan disease?
    Beyers, Nulda
    Gie, Robert
    PUBLIC HEALTH ACTION, 2013, 3 (03): : 190 - 190
  • [10] NYUS MALARIA VACCINE - ORPHAN AT BIRTH
    MARSHALL, E
    SCIENCE, 1983, 219 (4584) : 466 - 467